Philip Hempleman, Ardsley Partners Initiate Position in Supernus Pharmaceuticals Inc (SUPN)
Philip Hempleman has become a fan of Supernus Pharmaceuticals Inc (NASDAQ:SUPN). According to a recent filing with the Securities and Exchange Commission...
Posts Tagged ‘Samuel Isaly OrbiMed Advisors’
Goldman Capital Management Reduces Stake in Bacterin International Holdings Inc (BONE)
Goldman Capital Management Inc has reduced its exposure to Bacterin International Holdings Inc (NYSEMKT:BONE). In a recent filing with the Securities...
Sam Isaly, Orbimed Now Hold 53.3% of Response Biomedical
Sam Isaly‘s Orbimed Advisors focuses on healthcare investments, and it has now disclosed a change to its holdings of Response Biomedical Corp. (...
The Biggest Biogen Idec Inc. (BIIB) Bulls Around
Is Biogen Idec Inc. (NASDAQ:BIIB) a buy? In the financial blogosphere, there are a lot of analytical tools for Biogen Idec Inc. (NASDAQ:BIIB) traders...
Pfizer Inc. (PFE), Gilead Sciences, Inc. (GILD), Merck & Co., Inc. (MRK) Among Hedge Funds’ Favorite Pharma Stocks
We maintain a database of quarterly 13F filings from hundreds of hedge funds and other notable investors. Our research has shown that this information...
Should You Buy Vocera Communications Inc (VCRA)?
Vocera Communications Inc (NYSE:VCRA) was in 14 hedge funds’ portfolio at the end of the first quarter of 2013. VCRA has experienced an increase...
Is Given Imaging Ltd. (GIVN) Going to Burn These Hedge Funds?
Given Imaging Ltd. (NASDAQ:GIVN) was in 14 hedge funds’ portfolio at the end of March. GIVN has seen an increase in enthusiasm from smart money...
Is Array Biopharma Inc (ARRY) Going to Burn These Hedge Funds?
Is Array Biopharma Inc (NASDAQ:ARRY) a worthy stock to buy now? Investors who are in the know are buying. The number of bullish hedge fund bets advanced...
Is Acorda Therapeutics Inc (ACOR) Going to Burn These Hedge Funds?
Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds’ portfolio at the end of March. ACOR has experienced a decrease in hedge fund sentiment...
Impax Laboratories Inc (IPXL): Insiders Are Buying, Should You?
Impax Laboratories Inc (NASDAQ:IPXL) has seen an increase in activity from the world’s largest hedge funds of late. In the financial world, there...
Regeneron Pharmaceuticals Inc (REGN): Are Hedge Funds Right About This Stock?
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) investors should pay attention to an increase in activity from the world’s largest hedge funds lately...
Orbimed Advisors Takes a Major Stake in Ambit Biosciences Corp (AMBI)
In the smart money’s world, Samuel Isaly’s Orbimed Advisors reported a purchase of some 2.1 million shares of Ambit Biosciences Corp (NASDAQ:AMBI)...
Hedge Funds Are Betting On Gilead Sciences, Inc. (GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) was in 63 hedge funds’ portfolio at the end of March. GILD shareholders have witnessed an increase in hedge...
Here is What Hedge Funds Think About Infinity Pharmaceuticals Inc. (INFI)
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds’ portfolio at the end of March. INFI investors should be aware of a decrease in...
Is Biogen Idec Inc. (BIIB) Going to Burn These Hedge Funds?
Biogen Idec Inc. (NASDAQ:BIIB) has seen a decrease in activity from the world’s largest hedge funds in recent months. To most traders, hedge funds...
Amgen, Inc. (AMGN): Insiders Aren’t Crazy About It
Amgen, Inc. (NASDAQ:AMGN) was in 36 hedge funds’ portfolio at the end of the first quarter of 2013. AMGN shareholders have witnessed an increase...
Hedge Fund News: Warren Buffett, Steve Cohen, Sprint Nextel Corporation (S)
Editor’s Note: Related Tickers: Baidu.com, Inc. (ADR) (NASDAQ:BIDU), Micron Technology, Inc. (NASDAQ:MU), Yelp Inc (NYSE:YELP), Google Inc (NASDAQ...
Infinity Pharmaceuticals Inc. (INFI): Billionaire Steve Cohen’ SAC Up to 5% of This Stock
According to a 13G filed with the SEC, SAC Capital Advisors, a hedge fund managed by billionaire Steve Cohen, owned 2.4 million shares of Infinity Pharmaceuticals...
Here is What Hedge Funds Think About Antares Pharma Inc (ATRS)
Antares Pharma Inc (NASDAQ:ATRS) investors should pay attention to an increase in activity from the world’s largest hedge funds recently. In the...
Hedge Funds Are Selling XOMA Corp (XOMA)
XOMA Corp (NASDAQ:XOMA) investors should pay attention to a decrease in hedge fund interest lately. If you’d ask most investors, hedge funds are...
This Metric Says You Are Smart to Sell Endocyte, Inc. (ECYT)
Endocyte, Inc. (NASDAQ:ECYT) shareholders have witnessed a decrease in hedge fund sentiment in recent months. In the financial world, there are tons of...
Hedge Funds Aren’t Crazy About Fluidigm Corporation (FLDM) Anymore
Fluidigm Corporation (NASDAQ:FLDM) was in 7 hedge funds’ portfolio at the end of the fourth quarter of 2012. FLDM investors should pay attention...
Hedge Funds Are Buying Uroplasty, Inc. (UPI)
Is Uroplasty, Inc. (NASDAQ:UPI) an excellent investment now? The smart money is taking an optimistic view. The number of bullish hedge fund bets went...
Given Imaging Ltd. (GIVN): Hedge Funds and Insiders Are Bearish, What Should You Do?: Cynosure, Inc. (CYNO), Symmetry Medical Inc. (SMA)
Given Imaging Ltd. (NASDAQ:GIVN) was in 9 hedge funds’ portfolio at the end of December. GIVN shareholders have witnessed a decrease in support...
Hedge Funds Are Dumping Dendreon Corporation (DNDN): Achillion Pharmaceuticals, Inc. (ACHN), TESARO Inc (TSRO)
Dendreon Corporation (NASDAQ:DNDN) investors should pay attention to a decrease in support from the world’s most elite money managers recently....
Medivation Inc (MDVN), Amarin Corporation plc (ADR) (AMRN), Abbott Laboratories (ABT): Adage Capital Management Owns 5.4% of This Company
According to a 13G filed with the SEC, Adage Capital Management, a large hedge fund managed by Phil Gross and Robert Atchinson, owns just over 4 million...
Hedge Funds Aren’t Crazy About MAKO Surgical Corp. (MAKO) Anymore: The Spectranetics Corporation (SPNC), Symmetry Medical Inc. (SMA)
MAKO Surgical Corp. (NASDAQ:MAKO) was in 13 hedge funds’ portfolio at the end of December. MAKO investors should pay attention to a decrease in...
XenoPort, Inc. (NASDAQ:XNPT): Insiders Are Dumping, Should You?: Obagi Medical Products, Inc. (OMPI), Vical Incorporated (VICL)
XenoPort, Inc. (NASDAQ:XNPT) was in 13 hedge funds’ portfolio at the end of December. XNPT investors should be aware of a decrease in activity from...
Hedge Funds Aren’t Crazy About Neurocrine Biosciences, Inc. (NBIX) Anymore: Keryx Biopharmaceuticals (KERX), Rigel Pharmaceuticals, Inc. (RIGL)
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 12 hedge funds’ portfolio at the end of December. NBIX shareholders have witnessed a decrease...
Hedge Funds Are Betting On Natus Medical Inc (NASDAQ:BABY) – GenMark Diagnostics, Inc (NASDAQ:GNMK), Symmetry Medical Inc. (NYSE:SMA)
Natus Medical Inc (NASDAQ:BABY) was in 15 hedge funds’ portfolio at the end of December. BABY investors should pay attention to an increase in hedge...
Should You Buy Impax Laboratories Inc (NASDAQ:IPXL)?
Is Impax Laboratories Inc (NASDAQ:IPXL) a buy right now? Prominent investors are taking a bullish view. The number of bullish hedge fund positions advanced...
Hedge Funds Are Crazy About Sequenom, Inc. (NASDAQ:SQNM)
Sequenom, Inc. (NASDAQ:SQNM) was in 15 hedge funds’ portfolio at the end of December. SQNM shareholders have witnessed an increase in hedge fund...
Here is What Hedge Funds Think About OraSure Technologies, Inc. (NASDAQ:OSUR)
Is OraSure Technologies, Inc. (NASDAQ:OSUR) a buy right now? Prominent investors are buying. The number of long hedge fund positions increased by 1 in...
Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Are Hedge Funds Right About This Stock?
Is Regeneron Pharmaceuticals Inc (NASDAQ:REGN) a buy right now? Hedge funds are getting more bullish. The number of long hedge fund positions improved...
Do Hedge Funds and Insiders Love Warner Chilcott Plc (NASDAQ:WCRX)?
Is Warner Chilcott Plc (NASDAQ:WCRX) the right pick for your portfolio? The smart money is selling. The number of long hedge fund positions dropped by...
Should You Buy Life Technologies Corp. (NASDAQ:LIFE)?
Life Technologies Corp. (NASDAQ:LIFE) has seen an increase in support from the world’s most elite money managers recently. In today’s marketplace...
A Board Member Bought Over $300,000 of Abbott Labs
A member of Abbott Laboratories (NYSE:ABT)’s Board of Directors, William Osborn, recently bought 10,000 shares of stock at prices between $33.80 and...
Healthcare Investor Sam Isaly’s Top Stock Picks Include Pfizer
Sam Isaly’s Orbimed Advisors is a large health care fund investing in companies at various stages from venture capital to the public markets. The fund...
Billionaire Ken Fisher Thinks Pfizer Is Right For You
Billionaire Ken Fisher isn’t only the head of Fisher Asset Management, but also a long-running Forbes columnist whose picks published in that magazine...
Is Bristol Myers Squibb a Good Stock to Buy?
Bristol Myers Squibb Co. (NYSE:BMY) is down 5% so far this year, as the company saw bad news break in early August when it suspended a trial for its prospective...
Orbimed Still Selling Pacira
Between April and June of this year, Orbimed Advisors sold 18% of its shares of Pacira Pharmaceuticals Inc (NASDAQ:PCRX), finishing the second quarter...
Why is Orbimed Backing Out of Amarin?
Orbimed Advisors, managed by Samuel Isaly, is a hedge fund with a focus on the healthcare sector. At the end of June, according to Orbimed’s 13F filing...
Peter Kolchinsky’s RA Capital Management Raised Stake In Endocyte $ECYT
Peter Kolchinsky’s RA Capital Management reported 7.32% passive stake in Endocyte Inc. (ECYT). According to a regulatory filing, now RA Capital Management...
Samuel Isaly Reported Changes in His Third Quarter Holdings
Samuel Isaly reported his amended 13F portfolio on November 23rd. He made a lot of changes to his original third quarter 13F which was filed a few days...
Insider Trading: Samuel Isaly’s Orbimed Advisors is Selling $ANTH
Samuel Isaly’s Orbimed Advisors filed for its recent insider sales in Anthera Pharmaceuticals Inc (ANTH) on November 18th. According to the filing,...
Hedge Funds Make Big After Regeneron $REGN Gets FDA OK for Eylea
Regeneron Pharmaceuticals Inc.’s (REGN) shares rose 13.73% in trading on Monday after U.S. regulators approved its “drug Eylea to treat a...
Hedge Funds Make a Bundle on Inhibitex $INHX
Shares of Inhibitex (INHX) more than doubled Friday morning. The increase came “after the company released promising new data on its hepatitis C...
Hedge Funds Make Big on Humana $HUM
Humana Inc (HUM) swelled from $80.24 a share at open on Monday to hit anew 52-week high of $87.32 a share after it “announced earnings of $444.8...
Insider Trading: Daniel Gold’s QVT Financial Sold 650 Thousand Shares in $ANDS
Daniel Gold’s QVT Financial sold 650 thousand shares in Anadys Pharmaceuticals Inc. (ANDS) on October 17th. According to the firm’s Form 4 and amend...
Hedge Funds Make a Bundle on Edwards Lifesciences $EW Increase
Edwards Lifesciences Corp (EW) “third-quarter earnings rose 7.5% on a tax benefit as the heart-valve maker’s investments in its expected Sapien...
